Open AccessAssociation Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis
Author(s) -
Daniel H. Solomon
Publication year - 2011
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2011.878
Subject(s) - medicine , hydroxychloroquine , rheumatoid arthritis , psoriasis , methotrexate , context (archaeology) , cohort , tnf inhibitor , diabetes mellitus , arthritis , disease , etanercept , dermatology , endocrinology , paleontology , covid-19 , infectious disease (medical specialty) , biology
Rheumatoid arthritis (RA) and psoriasis have been linked with insulin resistance and diabetes mellitus (DM). Prior investigations suggest that systemic immunosuppressive drugs may improve insulin resistance and reduce the risk of DM.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom